IBM, Merck, Walmart joins drug blockchain JV

IBM

There is a landmark project on a blockchain that has just been announced.

A consortium of IBM Corp, Merck & Co, KPMG and Walmart Inc have just announced that they will be a part of U.S. Food and Drug Administration’s pilot program that will explore using blockchain.

The blockchain network will be used to identify, track and trace prescription drugs.

The joint venture said the companies said they would create a shared blockchain network to allow real-time monitoring of products in the pharmaceutical supply chain.